"N Engl J Med"[journal] 检索结果

1141. Neoadjuvant and Adjuvant Pembrolizumab in Locally Advanced Head and Neck Cancer.

作者: Ravindra Uppaluri.;Robert I Haddad.;Yungan Tao.;Christophe Le Tourneau.;Nancy Y Lee.;William Westra.;Rebecca Chernock.;Makoto Tahara.;Kevin J Harrington.;Arkadiy L Klochikhin.;Irene Braña.;Gustavo Vasconcelos Alves.;Brett G M Hughes.;Marc Oliva.;Iane Pinto Figueiredo Lima.;Tsutomu Ueda.;Tomasz Rutkowski.;Ursula Schroeder.;Paul-Stefan Mauz.;Thorsten Fuereder.;Simon Laban.;Nobuhiko Oridate.;Aron Popovtzer.;Nicolas Mach.;Yevhen Korobko.;Diogo Alpuim Costa.;Anupama Hooda-Nehra.;Cristina P Rodriguez.;R Bryan Bell.;Cole Manschot.;Kimberly Benjamin.;Burak Gumuscu.;Douglas Adkins.; .
来源: N Engl J Med. 2025年393卷1期37-50页

The benefit of the addition of perioperative pembrolizumab to standard care with surgery and adjuvant therapy for patients with locally advanced head and neck squamous-cell carcinoma (HNSCC) is unclear.

1142. Revised Recommendations for Covid-19 Vaccines - U.S. Vaccination Policy under Threat.

作者: Jason L Schwartz.
来源: N Engl J Med. 2025年393卷5期417-419页

1143. Biologic Drugs and Medicare Price Negotiation.

作者: Thomas J Hwang.;Nancy L Keating.;Stacie B Dusetzina.
来源: N Engl J Med. 2025年393卷1期6-9页

1144. Levofloxacin for the Prevention of Multidrug-Resistant Tuberculosis. Reply.

作者: Anneke C Hesseling.;H Simon Schaaf.;Susan E Purchase.
来源: N Engl J Med. 2025年392卷23期2391-2392页

1145. Levofloxacin for the Prevention of Multidrug-Resistant Tuberculosis. Reply.

作者: Greg J Fox.;Nguyen Viet Nhung.;Guy B Marks.
来源: N Engl J Med. 2025年392卷23期2390-2391页

1146. Levofloxacin for the Prevention of Multidrug-Resistant Tuberculosis.

作者: Mao-Shui Wang.
来源: N Engl J Med. 2025年392卷23期2390页

1147. Levofloxacin for the Prevention of Multidrug-Resistant Tuberculosis.

作者: Ronald Lubelchek.
来源: N Engl J Med. 2025年392卷23期2389-2390页

1148. Levofloxacin for the Prevention of Multidrug-Resistant Tuberculosis.

作者: Saul Malozowski.
来源: N Engl J Med. 2025年392卷23期2389页

1149. Oral Infigratinib Therapy in Children with Achondroplasia. Reply.

作者: Ravi Savarirayan.;Daniela Rogoff.
来源: N Engl J Med. 2025年392卷23期2388-2389页

1150. Oral Infigratinib Therapy in Children with Achondroplasia.

作者: Gustavo Rico-Llanos.;Aleksandra A Czyrek.;Pavel Krejci.
来源: N Engl J Med. 2025年392卷23期2388页

1151. Oral Infigratinib Therapy in Children with Achondroplasia.

作者: Stefan Bittmann.
来源: N Engl J Med. 2025年392卷23期2387-2388页

1152. Three Cases of Vertical Transmission of Clade Ib Mpox Virus.

作者: Emmanuel Hasivirwe Vakaniaki.;Nono-Raymond Swar Kuispond.;Yuichiro Hirata.;Eugene Bangwen.;Isabel Brosius.;Eddy Kinganda-Lusamaki.;Seiya Ozono.;Harutaka Katano.;Laurent Gabanga Ndunge.;Noella Mulopo-Mukanya.;Jean-Claude Tshomba.;Elise De Vos.;Christophe Van Dijck.;Papy Munganga.;Guy Mukari.;Yves Mujula.;Divin Mazambi Mambo.;Steeven Bilembo Kitwanda.;Nadine Maliyamungu-Bubala.;Léandre Mutimbwa-Mambo.;Ian Crozier.;Lori E Dodd.;Olivier Tshiani-Mbaya.;Bienvenu Massamba Lebwaze.;Espoir Bwenge Malembaka.;Isaac Barhishindi.;Susanne Krasemann.;Robert Colebunders.;Patrick D M C Katoto.;Sheila Makiala-Mandanda.;Jason Kindrachuk.;Anne W Rimoin.;Jean-Jacques Muyembe-Tamfum.;Daniel Mukadi-Bamuleka.;Tony Wawina-Bokalanga.;Sabin Sabiti Nundu.;Tadaki Suzuki.;Raphaël Bulakali Chirimwami.;Laurens Liesenborghs.;Placide Mbala-Kingebeni.
来源: N Engl J Med. 2025年392卷23期2385-2387页

1153. Myasthenia Gravis - Redemption for B-Cell Depletion.

作者: Gil I Wolfe.;Shahar Shelly.
来源: N Engl J Med. 2025年392卷23期2382-2384页

1154. Nonoperative Management of dMMR Tumors - A Patient-Centered Approach.

作者: Elena Elez.
来源: N Engl J Med. 2025年392卷23期2380-2382页

1155. Case 17-2025: A 61-Year-Old Man with Respiratory Failure and Shock after Kidney Transplantation.

作者: Camille N Kotton.;Rory L Cochran.;Alan M Sanders.;Kassem Safa.;Maxwell T Roth.
来源: N Engl J Med. 2025年392卷23期2368-2378页

1156. Generalized Pustular Psoriasis.

作者: Su-Chi Ku.;Ying-Yi Chiang.
来源: N Engl J Med. 2025年392卷23期2367页

1157. Unruptured Intracranial Aneurysms.

作者: Christopher S Ogilvy.
来源: N Engl J Med. 2025年392卷23期2357-2366页

1158. Bevacizumab and Erlotinib in Hereditary and Sporadic Papillary Kidney Cancer.

作者: Ramaprasad Srinivasan.;Sandeep Gurram.;Eric A Singer.;Abhinav Sidana.;Munjid Al Harthy.;Mark W Ball.;Julia C Friend.;Lisa Mac.;Erin Purcell.;Cathy D Vocke.;Christopher J Ricketts.;Heidi H Kong.;Edward W Cowen.;Ashkan A Malayeri.;Joanna H Shih.;Maria J Merino.;W Marston Linehan.
来源: N Engl J Med. 2025年392卷23期2346-2356页

Hereditary leiomyomatosis and renal-cell cancer (HLRCC) is an inherited disorder characterized by germline pathogenic variants in the gene encoding fumarate hydratase and an increased risk of papillary renal-cell carcinoma. No effective therapy is known for patients with advanced HLRCC-associated papillary renal-cell carcinoma, and most patients die from progressive disease.

1159. Harnessing Immunotherapy in Curative-Intent Treatment of Head and Neck Cancer.

作者: Ari J Rosenberg.;Everett E Vokes.
来源: N Engl J Med. 2025年393卷1期85-87页

1160. Medical AI and Clinician Surveillance - The Risk of Becoming Quantified Workers.

作者: I Glenn Cohen.;Ifeoma Ajunwa.;Ravi B Parikh.
来源: N Engl J Med. 2025年392卷23期2289-2291页

结果排序

文献格式

出版时间

出版类型

出版语言